The GPR179 gene encodes a G protein-coupled receptor (GPCR) that plays a crucial role in the visual signaling pathway within the retina. Below is additional information regarding GPR179, covering the specifics you requested.

### 1. Associated Genes
The GPR179 gene interacts primarily with several other genes involved in retinal signaling pathways and visual processes. Notably:

- **GRM6**: This gene encodes a metabotropic glutamate receptor that is essential for phototransduction in the retina and is known to interact with GPR179.
- **TRPM1**: This gene encodes a transient receptor potential (TRP) channel that is involved in the visual signal's transduction cascade and is associated with GPR179 signaling.
- **RGS9**: It is part of the R7 group of Regulator of G-protein Signaling proteins that are critical for GPR179-mediated signaling.
- **R7BP**: A binding protein that interacts with RGS9, potentially modulating its function.

### 2. Aging and Age-Related Diseases
While GPR179 is primarily linked to vision disorders, specific details on its association with aging or age-related diseases are less well-defined. However, given its role in retinal signaling, one might hypothesize that dysfunction in this pathway could contribute to age-related visual impairments, such as:

- **Age-related macular degeneration (AMD)**: Changes in signaling through bipolar cells may impact the overall health of the retina.
- **Retinitis pigmentosa**: Mutations affecting retinal signal transduction may lead to similar phenotypic manifestations, common in age-related retinal degenerations.

Research into the exact role of GPR179 in aging or age-related diseases remains an area of exploration.

### 3. Drug Interactions
As of now, specific drugs or drug classes that directly interact with GPR179 are not well documented. However, since GPR179 is an atypical GPCR linked to visual signaling, potential therapeutic agents affecting glutamate signaling in the retina might indirectly influence GPR179 pathways. 

- **Glutamate receptor modulators**: Although there are no direct interactions reported, medications that influence glutamate signaling may affect the downstream pathways involving GPR179, akin to treatments aimed at AMD or other retinal diseases.

### 4. Pathways and Biological Processes
GPR179 is implicated in several key biological processes and signaling pathways:

- **Retinal Signal Transduction**: It is a crucial component in the signaling cascade in retinal ON-bipolar cells, modulating the response to light through interactions with GRM6 and TRPM1.
- **G Protein-Coupled Receptor Signaling Pathway**: GPR179 operates within the broader context of GPCRs regulating various physiological processes.
- **Biological Rhythm Regulation**: GPR179 may partake in processes associated with circadian rhythms given its role in retinal signaling, although explicit pathways need to be investigated further.

### Conclusion
In summary, GPR179 is an orphan receptor involved in retinal signaling and is essential for visual transduction in the retina. Mutations can lead to congenital stationary night blindness type 1E. Its interactions with other retinal signaling components suggest a critical role in the functionality of the visual system, potentially implicating it in age-related visual conditions, though research in this area continues.